The Role Of Nitric Oxide After Repeated Low Dose Photodynamic Treatments In Prostate Carcinoma Cells.
Photodynamic therapy (PDT) is a clinically approved treatment that causes a selective cytotoxic effect in cancer cells. In addition to the production of singlet oxygen and reactive oxygen species, PDT can induce the release of nitric oxide (NO) by up-regulating nitric oxide synthases (NOS). Since non-optimal PDT often causes tumor recurrence, understanding of the molecular pathways involved in the photoprocess is a challenging task for scientists. The present study has examined the response of the PC3 human metastatic prostate cancer cell line, following repeated low-dose pheophorbide a treatments, mimicking non-optimal PDT treatment. The analysis was focused on the NF-kB/YY1/RKIP circuitry as it is (i) dysregulated in cancer cells (ii) modulated by NO and (iii) correlated with the epithelial to mesenchymal transition (EMT). We hypothesized that a repeated treatment of non-optimal PDT induces low levels of NO that lead to cell growth and EMT via regulation of the above circuitry. The expressions of gene products involved in the circuitry and in EMT were analyzed by western blot. The findings demonstrate the cytoprotective role of NO following non-optimal PDT treatments that was corroborated by the use of l-NAME, an inhibitor of NOS.
Department of Medical and Biological Sciences, University of Udine, Italy.
Valentina
V
Rapozzi
Department of Medical and Biological Sciences, University of Udine, Italy.
Emilia Della
ED
Pietra
Jonsson Comprehensive Cancer Center, University of California, Los Angeles, USA.
Benjamin
B
Bonavida
Department of Medical and Biological Sciences, University of Udine, Italy.
Luigi Emilio
LE
Xodo
D058750:Epithelial-Mesenchymal Transition; D006801:Humans; D008297:Male; D009569:Nitric Oxide / Q000378:metabolism*; D010778:Photochemotherapy; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000378:metabolism*; D015398:Signal Transduction
D009569:Nitric Oxide